10.89.Z - Production of other food products, not elsewhere classified
10.86.Z - Production of homogenized food products and diet food
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.99.Z - Retail trade
71.20.A - Food quality testing and analysis
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 302,7 | 263,7 | 169,2 | -35,8 |
Gross profit (loss) | -42,1 | -124 | -158,3 | -27,7 |
EBITDA | -32,1 | -110 | -110,3 | -0,3 |
Net profit (loss) | -42,1 | -124 | -158,3 | -27,7 |
Cash | 141,1 | 5,9 | 2,7 | -54,8 |
Liabilities and provisions for liabilities | 213,6 | 298,6 | 362,4 | 21,4 |
Net income from sale | 295,3 | 246,9 | 175,8 | -28,8 |
Short time liabilities | 213,6 | 233,6 | 315,5 | 35,1 |
Working assets | 302,7 | 141,8 | 77,4 | -45,4 |
Equity capital | 89,1 | -34,9 | -193,2 | -453,6 |
Operating profit (EBIT) | -35,5 | -110 | -140,6 | -27,9 |
Depreciation | 3,4 | 0 | 30,3 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -47,2 | 355,3 | 81,9 | -273,4 |
Equity capital to total assets | 29,4 | -13,2 | -114,2 | -101 |
Gross profit margin | -14,2 | -50,2 | -90 | -39,8 |
EBITDA Margin | -10,9 | -44,5 | -62,8 | -18,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 264 | 345 | 655 | 310 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane